Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
Conditions
- Moderate-to-severe Ulcerative Colitis
- Crohn's Disease (CD)
Interventions
- DRUG: RD06-05 CART Cell Infusion
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology